Gastroesophageal Reflux Disease Gerd clinical trials

Explore recruiting gastroesophageal reflux disease gerd clinical trials.

Recruiting gastroesophageal reflux disease gerd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastroesophageal Reflux Disease Gerd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, phase 3, double-blind, double-dummy, active comparator-controlled multicenter study to evaluate the efficacy and safety of 2 doses of linaprazan glurate compared to lansoprazole in 4 or 8 weeks healing in participants with erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) of Los Angeles (LA) grades A to D

Germany, Poland, Hungary, Bulgaria, Romania, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, phase 3, double-blind, double-dummy, active comparator-controlled multicenter clinical trial to evaluate the efficacy and safety of linaprazan glurate compared to lansoprazole in maintenance of healing in participants with healed erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) of Los Angeles (LA) grades A to D

Hungary, Germany, Romania, Bulgaria, Czechia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment of Gastroesophageal Reflux Disease in Infants- a Randomized Controlled Trial

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

Gastroesophageal Reflux Disease Gerd trials by city

Gastroesophageal Reflux Disease Gerd in Toronto Gastroesophageal Reflux Disease Gerd in Vancouver Gastroesophageal Reflux Disease Gerd in Montreal Gastroesophageal Reflux Disease Gerd in Calgary Gastroesophageal Reflux Disease Gerd in Edmonton Gastroesophageal Reflux Disease Gerd in Ottawa Gastroesophageal Reflux Disease Gerd in Winnipeg Gastroesophageal Reflux Disease Gerd in Quebec City Gastroesophageal Reflux Disease Gerd in Hamilton Gastroesophageal Reflux Disease Gerd in Kitchener Gastroesophageal Reflux Disease Gerd in London Gastroesophageal Reflux Disease Gerd in Halifax Gastroesophageal Reflux Disease Gerd in New York Gastroesophageal Reflux Disease Gerd in Los Angeles Gastroesophageal Reflux Disease Gerd in Chicago Gastroesophageal Reflux Disease Gerd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease